Copy number (CN) analysis revealed recurrent gains of 1q, 8q, 16p, 17q, and 20q, and losses of 1p, 4p, 8p, 11p, and 17p in the 24 PALB2-associated breast cancers analyzed (Fig. 2). Here, PALB2 is linked to breast carcinoma.